Patents by Inventor Ian Francis Hassan

Ian Francis Hassan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations of formoterol and mometasone furoate for asthma
    Patent number: 7067502
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Grant
    Filed: November 20, 2003
    Date of Patent: June 27, 2006
    Assignee: Novartis AG
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Henry Luke Danahay
  • Combinations of formoterol and mometasone furoate for asthma
    Publication number: 20040105822
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Application
    Filed: November 20, 2003
    Publication date: June 3, 2004
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Henry Luke Danahay
  • Combinations of formoterol and fluticasone propionate for asthma
    Publication number: 20040101487
    Abstract: A pharmaceutical composition comprising (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) fluticasone propionate, suitable for use in the treatment of inflammatory or obstructive airways diseases.
    Type: Application
    Filed: November 20, 2003
    Publication date: May 27, 2004
    Inventors: Jeremy Guy Clarke, Henry Luke Danahay, Ian Francis Hassan
  • Combinations of formoterol and a tiotropium salt
    Patent number: 6537524
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) a tiotropium salt of a pharmaceutically acceptable acid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: March 25, 2003
    Assignee: Novartis AG
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Bernard Cuenoud
  • Combination of formoterol and mometasone furoate for asthma
    Publication number: 20030050290
    Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Type: Application
    Filed: October 1, 2002
    Publication date: March 13, 2003
    Inventors: Ian Francis Hassan, Jeremy Guy Clarke, Henry Luke Danahay
  • Combinations of formoterol and fluticasone proppionate for asthma
    Publication number: 20020103260
    Abstract: A pharmaceutical composition comprising (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) fluticasone propionate, suitable for use in the treatment of inflammatory or obstructive airways diseases.
    Type: Application
    Filed: August 15, 2001
    Publication date: August 1, 2002
    Inventors: Jeremy Guy Clarke, Henry Luke Danahay, Ian Francis Hassan
  • Desferrioxamine-B salts and their use as orally effective iron chelators
    Patent number: 5739167
    Abstract: A salt of formula (I) where X denotes a group of formula (II), Y denotes a group of formula (III) and R denotes the residue of an aliphatic or cycloaliphatic sulphonic acid having at least 3 carbon atoms after removal of an --SO.sub.3 H group therefrom.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: April 14, 1998
    Assignee: Novartis Corporation
    Inventors: Nicholas Lowther, Ian Francis Hassan, Ian Timothy William Matthews
  • Desferrioxamine-B salts
    Patent number: 5663201
    Abstract: A salt of formula ##STR1## where X denotes a group of formula ##STR2## Y denotes a group of formula ##STR3## and R denotes the residue of an aliphatic or cycloaliphatic sulphonic acid having at least 3 carbon atoms after removal of a --SO.sub.3 H group therefrom.
    Type: Grant
    Filed: March 11, 1996
    Date of Patent: September 2, 1997
    Assignee: CIBA-GEIGY Corporation
    Inventors: Nicholas Lowther, Ian Francis Hassan, Ian Timothy William Matthews